Kemin highlights positive ageing at SupplySide Global

As part of this positive ageing vision, Kemin will highlight how advances in lutein research are extending nutritional carotenoids’ applications beyond vision towards a wider impact on human health. The company will also spotlight its Gutopia™ gut health platform and complementary solutions designed to support the GLP-1 experience.

30 years of human impact: FloraGLO^® and positive ageing

At its booth, Kemin will highlight three decades of FloraGLO^® lutein, the first and most extensively studied lutein brand. With more than 130 human clinical studies, scientific research on FloraGLO^® has established lutein and zeaxanthin as key carotenoids for health throughout life, with increasing evidence demonstrating their role beyond vision, including cognitive function and skin health.1

Visitors to Kemin’s booth will discover the importance of adequate lutein intake and how FloraGLO^® can help bridge this nutritional gap to support positive ageing. Despite benefits evidenced across life stages, the general population consumes just one to three milligrams a day on average, far below the levels research has shown to be beneficial.2,3,4,5,6 The science will also come to life with an interactive eye test, where attendees can receive a personalised FloraGLO^® EyeQ score and insight into their own nutritional status.

Putting gut health at the centre of ageing well

As consumer awareness of gut health and its wider connections grows, it is becoming an increasingly important part of the positive-ageing conversation. Kemin is tapping into this opportunity with its platform of solutions for Gutopia™.

Bringing together science-led ingredients that support gut health from multiple complementary angles, Kemin’s Gutopia™ portfolio includes BetaVia™, an algae-based beta-glucan postbiotic for gut and immune health7,8, and ButiShield™, an encapsulated butyric acid ingredient for digestive wellness.9 Kemin’s experts will be at the booth to help brands explore how these different approaches could help them support health and wellbeing across the ageing journey via the gut.

Supporting the GLP-1 experience

For many consumers, weight management is increasingly connected to a bigger ambition: supporting long-term health and quality of life. In the US, 59% of people believe that their entire lives would improve if they lost weight, while more than one-third (37%) believe it would help them live longer.10 This is not only helping fuel interest in GLP-1 drugs, but also other nutritional strategies for weight management as part of a long-term approach to health.

Responding to this evolving landscape, Kemin will highlight Slendesta^®, a potato-derived ingredient for promoting satiety. By enhancing a natural satiety response, Slendesta^® helps support appetite control in a way that is gentle, non-stimulating and aligned with the body’s own fullness signals. Working through the gut-brain axis, it enhances the release of a gut hormone that delays gastric emptying and helps signal fullness to the brain, helping regulate glucose levels after eating.11,12,13,14,15 The ingredient can be used to complement GLP-1 therapies, help maintain satiety while transitioning off them, or offer an alternative for people seeking non-medical appetite support.

A full portfolio for all ages and stages

Speaking on the upcoming show, Filipa Quintela, Associate Director Marketing at Kemin Nutrition & Health, said, “Positive ageing is about helping people get more from the years they live – and nutrition has an important role to play. Nature gives us an extraordinary starting point, but scientific discovery helps us understand how its potential can be harnessed for health. Kemin’s 30-year journey with FloraGLO^® is a powerful example of this, showing how one area of discovery can open the door to new possibilities across the lifespan. Our offering at this year’s SupplySide Global is a celebration of being curious, following the science, and asking what might be possible to help our customers bring to life solutions which can transform people’s lives.”

Find out more about Kemin’s range of ingredients at SupplySide Global 2026 by visiting booth 6073.

REFERENCES

1. PubMed search up to December 2025, summarised in Sakai Y., Vaquero G. and Maci S. (2026), FloraGLO Clinically Proven and Most Researched Lutein Brand Worldwide, Kemin document KHTL-017-198.

2. Ranard, Katherine M., et al. “Dietary Guidance for Lutein: Consideration for Intake Recommendations Is Scientifically Supported.” European Journal of Nutrition, vol. 56, suppl. 3, 2017, pp. 37–42. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715043/

3. Johnson EJ, Maras JE, Rasmussen HM, Tucker KL. Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. J Am Diet Assoc. 2010;110(9):1357–1362. doi:10.1016/j.jada.2010.06.009

4. O’Neill ME, Carroll Y, Corridan B, Olmedilla B, Granado F, Blanco I, et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr. 2001;85(4):499–507. doi:10.1079/BJN2000284

5. Granado F, Blázquez S, Olmedilla B. Changes in carotenoid intake from fruit and vegetables in the Spanish population over the period 1964–2004. Public Health Nutr. 2007;10(10):1018–1023. doi:10.1017/S1368980007662314

6. Cena H, Roggi C, Turconi G. Development and validation of a brief food frequency questionnaire for dietary lutein and zeaxanthin intake assessment in Italian women. Eur J Nutr. 2008;47(1):1–9. doi:10.1007/s00394-007-0689-0

7. KHTL-017-180 BetaVia™ A Natural New-Generation Postbiotic that works as both an Immune Gut Health Promoter.

8. Evans, M. et al. Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 11, 2926 (2019).

9. Overholtzer E, Fonseca B. and Lucas R. Oral Supplementation of an Encapsulated Calcium Butyrate (ButiShield) Supports Gut Health in Healthy Adults with Mild GI Symptoms. Presented at Probiota America 2025 conference; https://clinicaltrials.gov/study/NCT06397482?term=calcium%20butyrate&rank=2
   ClinicalTrials.gov: http://clinicaltrials.gov/

10. Hims & Hers, The Shape of America Report, 2024.

11. Blundell, J. E. The control of appetite: basic concepts and practical implications. Schweiz Med Wochenschr. 1999;129:182–188.

12. Zhu Y, Lasrado JA, Hu J. Potato protease inhibitor II suppresses postprandial appetite in healthy women: a randomized double-blind placebo-controlled trial. Food Funct. 2017;8(5):1988–1993.

13. Spreadbury D, Shao A, Essman M, Sheabar FS, Geletta S, Larsen B. A proteinase inhibitor extract from potatoes reduces post-prandial blood glucose in human subjects. JANA. 2003;6(1):29–38.

14. Blundell JE. The control of appetite: basic concepts and practical implications. Schweiz Med Wochenschr. 1999;129(5):182–188.

15. Rehfeld JF. Cholecystokinin – portrayal of an unfolding peptide messenger system. Peptides. 2025;186:171369.